Section 337 Investigations; Notice of Commission Determination To Extend Postponement of all In-Person Section 337 Hearings Until June 10, 2020, 22177-22178 [2020-08388]

Download as PDF Federal Register / Vol. 85, No. 77 / Tuesday, April 21, 2020 / Notices funerary objects were excavated from 40BN25, the Ledbetter Landing archeological site in Benton County, TN. This notice is published as part of the National Park Service’s administrative responsibilities under NAGPRA, 25 U.S.C. 3003(d)(3) and 43 CFR 10.11(d). The determinations in this notice are the sole responsibility of the museum, institution, or Federal agency that has control of the Native American human remains and associated funerary objects. The National Park Service is not responsible for the determinations in this notice. lotter on DSKBCFDHB2PROD with NOTICES Consultation A detailed assessment of the human remains and associated funerary objects was made by TVA professional staff in consultation with representatives of the Cherokee Nation; Coushatta Tribe of Louisiana; Eastern Band of Cherokee Indians; The Chickasaw Nation; The Muscogee (Creek) Nation; The Osage Nation (previously listed as Osage Tribe); The Seminole Nation of Oklahoma; Thlopthlocco Tribal Town; and the United Keetoowah Band of Cherokee Indians in Oklahoma (hereafter referred to as ‘‘The Consulted Tribes’’). History and Description of the Remains Site 40BN25 was excavated as part of TVA’s Kentucky reservoir project by the University of Tennessee, using labor and funds provided by the Works Progress Administration. Details regarding these excavations have not been published. A field report by George Lindberg regarding this site can be found at the MM and TVA. The human remains and associated funerary objects listed in this notice have been in the physical custody of the University of Tennessee since excavation, but are under the control of the TVA. From October-to-December 1940, human remains representing, at minimum, 128 individuals were removed from site 40BN25, in Benton County, TN. These human remains represent 39 females, 28 male and 61 individuals of undeterminable sex. They also represent adults, sub-adults, and infants. No known individuals were identified. The 1,478 associated funerary objects include 79 animal bones, nine antler tine fragments, three antler tools, one bannerstone, 14 bone awls, 19 bone awl fragments, five bone pin fragments, three chert drills, one chert graver, one conch shell pendant, two copper beads, one cut and polished mountain lion femur, seven pieces of debitage, one modified human femur, one metal fragment, one pebble in red ochre, one perforated copper object, one VerDate Sep<11>2014 21:19 Apr 20, 2020 Jkt 250001 perforated pebble, one perforated shell discoidal, one perforated shell with copper, 23 projectile points, one sample of red ochre, three pieces of sediment, 1,281 shell beads, five sherds, one whetstone, one worked antler, and 11 worked bone or bone fragments. Excavation on 40BN25 commenced after TVA had acquired the land encompassing this site on July 11, 1940. Excavations identified two strata. Stratum I was 60 centimeters thick and contained ceramics attributed to the Early Woodland period. Stratum II was 75 centimeters thick and represented a Late Archaic occupation. Stratum II was the least disturbed by plowing, construction of warehouses, and looting. No post mold patterns indicative of structures were identified. In his 2014 dissertation, Thaddeus Bissett presented three radiocarbon dates from this site. He generated a calibrated date of 2636 ±89 Before the Present (BP) from carbonized material from Stratum I. From Stratum II, he got two calibrated dates, 4489 ±88 BP and 4314 ±79 BP. Based on these radiocarbon dates and the stratigraphic distribution of projectile points, Bissett verifies that Stratum II was Late Archaic and Stratum I was an Early Woodland occupation. Determinations Made by the Tennessee Valley Authority Officials of the Tennessee Valley Authority have determined that: • Pursuant to 25 U.S.C. 3001(9), the human remains described in this notice are Native American based on their presence in prehistoric archeological sites and osteological analysis. • Pursuant to 25 U.S.C. 3001(9), the human remains described in this notice represent the physical remains of 128 individuals of Native American ancestry. • Pursuant to 25 U.S.C. 3001(3)(A), the 1,478 objects described in this notice are reasonably believed to have been placed with or near individual human remains at the time of death or later as part of the death rite or ceremony. • Pursuant to 25 U.S.C. 3001(2), a relationship of shared group identity cannot be reasonably traced between the Native American human remains and associated funerary objects and any present-day Indian Tribe. • The Treaty of October 19, 1818, indicates that the land from which the cultural items were removed is the aboriginal land of The Chickasaw Nation. • Pursuant to 43 CFR 10.11(c)(1)(ii), the disposition of the human remains PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 22177 and associated funerary objects may be to The Chickasaw Nation. Additional Requestors and Disposition Representatives of any Federallyrecognized Indian Tribe not identified in this notice that wish to request transfer of control of these human remains and associated funerary objects should submit a written request with information in support of the request to Dr. Thomas O. Maher, Tennessee Valley Authority, 400 West Summit Hill Drive, WT11C, Knoxville, TN 37902–1401, telephone (865) 632–7458, email tomaher@tva.gov, by May 21, 2020. After that date, if no additional requestors have come forward, transfer of control of the human remains and associated funerary objects to The Chickasaw Nation may proceed. The Tennessee Valley Authority is responsible for notifying The Consulted Tribes that this notice has been published. Dated: March 25, 2020. Melanie O’Brien, Manager, National NAGPRA Program. [FR Doc. 2020–08366 Filed 4–20–20; 8:45 am] BILLING CODE 4312–52–P INTERNATIONAL TRADE COMMISSION Section 337 Investigations; Notice of Commission Determination To Extend Postponement of all In-Person Section 337 Hearings Until June 10, 2020 U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined to extend postponement of all in-person hearings under section 337 of the Tariff Act of 1930, as amended, until June 10, 2020. FOR FURTHER INFORMATION CONTACT: Lisa R. Barton, Secretary to the Commission, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its internet server at United States International Trade Commission (USITC) at https://www.usitc.gov/. The public record for section 337 investigations may be viewed on the Commission’s Electronic Document Information System (EDIS) at https:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUMMARY: E:\FR\FM\21APN1.SGM 21APN1 22178 Federal Register / Vol. 85, No. 77 / Tuesday, April 21, 2020 / Notices In light of the ongoing Coronavirus (COVID–19) outbreak, the Commission has determined to extend postponement of all section 337 in-person hearings until June 10, 2020. Commission Administrative Law Judges (‘‘ALJ’’) are directed to notify all affected parties and to schedule new dates for the hearings as appropriate. ALJs may otherwise conduct their investigations in accordance with their established procedures. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). SUPPLEMENTARY INFORMATION: By order of the Commission. Issued: April 15, 2020. Lisa Barton, Secretary to the Commission. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.33(a), this is notice that on September 3, 2018, Cedarburg Pharmaceuticals, 870 Badger Circle, Grafton, Wisconsin 53024–0000 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: SUPPLEMENTARY INFORMATION: Drug code Controlled substance Tetrahydrocannabinols .. Methylphenidate ............ Nabilone ........................ 4-Anilino-N-phenethyl-4piperidine (ANPP). Fentanyl ......................... Schedule 7370 1724 7379 8333 I II II II 9801 II [FR Doc. 2020–08388 Filed 4–20–20; 8:45 am] The company plans to manufacture bulk active pharmaceutical ingredients (API) for distribution to its customers. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to bulk manufacture as synthetic. No other activity for this drug code is authorized for this registration. BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–596] Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals ACTION: William T. McDermott, Assistant Administrator. [FR Doc. 2020–08352 Filed 4–20–20; 8:45 am] Notice of application. BILLING CODE 4410–09–P Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 22, 2020. DATES: DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–606] Importer of Controlled Substances Application: Sigma Aldrich Co., LLC ACTION: Notice of application. Registered bulk manufacturer of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 21, 2020. Such persons may also file a written request for a hearing on the application on or before May 21, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on January 27, 2020, Sigma Aldrich Co., LLC, 3500 DeKalb Street, Saint Louis, Missouri 63118 applied to be registered as an importer of the following basic class(es) of controlled substances: DATES: lotter on DSKBCFDHB2PROD with NOTICES Controlled substance Drug code Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... Gamma Hydroxybutyric Acid ........................................................................................................................................... Tetrahydrocannabinols .................................................................................................................................................... 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 2,5-Dimethoxyamphetamine ............................................................................................................................................ 3,4-Methylenedioxyamphetamine .................................................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ 4-Methoxyamphetamine .................................................................................................................................................. Dimethyltryptamine .......................................................................................................................................................... N-Benzylpiperazine .......................................................................................................................................................... Heroin .............................................................................................................................................................................. Normorphine .................................................................................................................................................................... Amobarbital ...................................................................................................................................................................... Secobarbital ..................................................................................................................................................................... Nabilone ........................................................................................................................................................................... Phencyclidine ................................................................................................................................................................... Ecgonine .......................................................................................................................................................................... Ethylmorphine .................................................................................................................................................................. VerDate Sep<11>2014 21:19 Apr 20, 2020 Jkt 250001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\21APN1.SGM 21APN1 1235 1237 1248 2010 7370 7391 7392 7396 7400 7404 7405 7411 7435 7493 9200 9313 2125 2315 7379 7471 9180 9190 Schedule I I I I I I I I I I I I I I I I II II II II II II

Agencies

[Federal Register Volume 85, Number 77 (Tuesday, April 21, 2020)]
[Notices]
[Pages 22177-22178]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08388]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION


Section 337 Investigations; Notice of Commission Determination To 
Extend Postponement of all In-Person Section 337 Hearings Until June 
10, 2020

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined to extend postponement of all in-person 
hearings under section 337 of the Tariff Act of 1930, as amended, until 
June 10, 2020.

FOR FURTHER INFORMATION CONTACT: Lisa R. Barton, Secretary to the 
Commission, U.S. International Trade Commission, 500 E Street SW, 
Washington, DC 20436, telephone (202) 205-2000. General information 
concerning the Commission may also be obtained by accessing its 
internet server at United States International Trade Commission (USITC) 
at https://www.usitc.gov/. The public record for section 337 
investigations may be viewed on the Commission's Electronic Document 
Information System (EDIS) at https://edis.usitc.gov. Hearing-impaired 
persons are advised that information on this matter can be obtained by 
contacting the Commission's TDD terminal on (202) 205-1810.

[[Page 22178]]


SUPPLEMENTARY INFORMATION: In light of the ongoing Coronavirus (COVID-
19) outbreak, the Commission has determined to extend postponement of 
all section 337 in-person hearings until June 10, 2020. Commission 
Administrative Law Judges (``ALJ'') are directed to notify all affected 
parties and to schedule new dates for the hearings as appropriate. ALJs 
may otherwise conduct their investigations in accordance with their 
established procedures.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    By order of the Commission.

    Issued: April 15, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020-08388 Filed 4-20-20; 8:45 am]
BILLING CODE 7020-02-P